Safety and Tolerability of Intravenous LLP2A-Alendronate for Osteopenia Secondary to Glucocorticoids
Clinical trial NCT03197623 · COMPLETED
Trial details
- NCT number
- NCT03197623
- Sponsor
- Nancy E. Lane, MD
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-14
- Primary completion
- 2021-03-15
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.